UNIVARIATE ANALYSIS | ||||
---|---|---|---|---|
Variables | OR | PFS | ||
HR (95% CI) | p-value | HR (95%CI) | p-value | |
Treatment Group | ||||
CD3+ | 0.80 (0.20-3.25) | 0.70 | 0.94 (0.45-1.94) | 0.91 |
CD4+ | 1.31 (0.32-1.49) | 0.36 | 0.74 (0.35-1.58) | 0.41 |
CD8+ | 0.86 (0.22-3.58) | 0.74 | 0.84 (0.45-1.72) | 0.62 |
CD56+ | 7.75 (1.13-42.6) | 0.012 | 2.70 (1.25-5.88) | 0.005 |
CD68+ | 1.25 (0.79-7.72) | 0.55 | 1.16 (0.55-2.46) | 0.69 |
Foxp3+ | 0.54 (0.20-3.50) | 0.98 | 0.89 (0.43-1.83) | 0.81 |
K-ras status | ||||
WT vs MT | 12.81 (2.15-7.7) | 0.008 | 4.36 (1.77-10.7) | 0.0007 |
Control Group | ||||
CD3+ | 0.91 (0.41-4.11) | 0.63 | 0.84 (0.38-3.98) | 0.74 |
CD4+ | 1.51 (0.61-2.74) | 0.54 | 0.94 (0.52-2.98) | 0.52 |
CD8+ | 1.32 (0.59-2.42) | 0.31 | 1.20 (0.59-2.31) | 0.76 |
CD56+ | 1.21 (0.74-2.07) | 0.29 | 1.11 (0.81-1.56) | 0.14 |
CD68+ | 0.84 (0.58-2.11) | 0.36 | 0.87 (0.44-3.52) | 0.27 |
Foxp3+ | 0.66 (0.34-1.92) | 0.68 | 0.71 (0.88-1.56) | 0.13 |
MULTIVARIATE ANALYSIS | ||||
Variables | OR | PFS | ||
HR (95% CI) | p-value | HR (95%CI) | p-value | |
CD56 | ||||
Negative | 1 | 1 | ||
Positive | 7.05 | 0.04 | 2.62 | 0.0019 |
(1.49-45.76) | (1.14-6.00) | |||
K-ras | ||||
Mutated | 1 | 1 | ||
Wild Type | 11.7 | 0.013 | 4.74 | 0.001 |
(1.77-8.33) | (1.8-12.3) |